# Pharmacologic Strategies to Use the Levonorgestrel Implant in HIV-infected Women

> **NCT02722421** · PHASE2 · COMPLETED · sponsor: **University of Nebraska** · enrollment: 28 (actual)

## Conditions studied

- HIV
- Contraception

## Interventions

- **DRUG:** Levonorgestrel
- **DRUG:** Efavirenz

## Key facts

- **NCT ID:** NCT02722421
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-06
- **Primary completion:** 2019-12-05
- **Final completion:** 2020-03-30
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2024-10-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02722421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02722421, "Pharmacologic Strategies to Use the Levonorgestrel Implant in HIV-infected Women". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02722421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*